The Food and Drug Administration (FDA) announced this week that its investigation into a recent outbreak of botulism in infants, associated with spore-contaminated formula produced by ByHeart, is ongoing. The FDA has stated that it is focusing on the ingredients involved but has not yet determined how the bacteria contaminated the formula or how to prevent future occurrences. Three companies involved in the investigation are reportedly not accepting responsibility for the contamination.
✓ AI-Debiased Article
FDA Investigates Baby Botulism Outbreak Linked to Contaminated Formula
The FDA is continuing its investigation into a botulism outbreak in infants linked to contaminated formula from ByHeart. The agency has not yet identified the source of the contamination or how to prevent it in the future, while companies involved have not taken responsibility.
Companies
ByHeart
Annotating as
No note attached
on this article.
Bias Analysis
Bias score
25/100
wirepublicmainstream
flavoredpartisanadvocacy
Inflammatory language
15/100
Sentiment
-10/100
Bias Indicators Removed
- ✕ underwhelming
- ✕ devastating
- ✕ pointing fingers
Original vs. Neutral
Original Headline
Baby botulism outbreak: FDA still doesn't know cause—or how to prevent it
Neutral Headline
FDA Investigates Baby Botulism Outbreak Linked to Contaminated Formula
